Atrial Fibrillation Ablation in Congenital Heart Disease: Therapeutic Challenges and Future Perspectives.

Authors:
Baroutidou A; Otountzidis N; Papazoglou AS; Moysidis DV; Kartas A and 4 more

Journal:
J Am Heart Assoc

Publication Year: 2024

DOI:
10.1161/JAHA.123.032102

PMCID:
PMC10926799

PMID:
38193287

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Am Heart Assoc

Abbreviation: J Am Heart Assoc

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acceptability of a Text Message-Based Mobile Health Intervention to Promote Physical Activity in Ca…
Atluri N; Mishra SR; Anderson T and 5 more (2024) - Transparency Score: 5/6
Acute Coronary Syndrome Subphenotypes Based on Repeated Biomarker Measurements in Relation to Long-…
de Bakker M; Scholte NTB; Oemrawsingh RM and 22 more (2024) - Transparency Score: 5/6
Advancing Cardiovascular Health Equity Globally Through Digital Technologies.
Ogungbe O; Longenecker CT; Beaton A and 6 more (2024) - Transparency Score: 3/6
A Physical Activity and Diet Just-in-Time Adaptive Intervention to Reduce Blood Pressure: The myBPm…
Golbus JR; Jeganathan VSE; Stevens R and 11 more (2024) - Transparency Score: 4/6
Arterial Stiffness and Carotid Intima-Media Thickness in Children Exposed to Smokeless Tobacco in F…
Nordenstam F; Norman M; Caidahl K and 1 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures None."

Evidence found in paper:

"Sources of Funding This work was supported by Pfizer through the European Thrombosis Investigator Initiated Research Program (ERISTA, Reference Number: WI246683). The funder had no role in the design or conduct of the study; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025